MCID: FNC032
MIFTS: 41

Fanconi Anemia, Complementation Group B malady

Category: Genetic diseases (common)

Aliases & Classifications for Fanconi Anemia, Complementation Group B

About this section

Aliases & Descriptions for Fanconi Anemia, Complementation Group B:

Name: Fanconi Anemia, Complementation Group B 51 12 67
Fanconi Anemia Complementation Group B 69 26
Fanconi Pancytopenia Type 2 69
 
Fancb 69
Fa2 69

Characteristics:

HPO:

63
fanconi anemia, complementation group b:
Inheritance: x-linked recessive inheritance

Classifications:



External Ids:

OMIM51 300514
MedGen36 C1845292
MeSH38 D005199

Summaries for Fanconi Anemia, Complementation Group B

About this section
OMIM:51 Fanconi anemia (FA) is a clinically and genetically heterogeneous disorder that causes genomic instability.... (300514) more...

MalaCards based summary: Fanconi Anemia, Complementation Group B, also known as fanconi anemia complementation group b, is related to vacterl with hydrocephalus, fancb-related and fancb-related fanconi anemia, and has symptoms including renal agenesis, low-set ears and growth delay. An important gene associated with Fanconi Anemia, Complementation Group B is FANCB (Fanconi Anemia Complementation Group B), and among its related pathways are DNA damage_ATM/ATR regulation of G1/S checkpoint and Chks in Checkpoint Regulation. Affiliated tissues include bone marrow, bone and lung, and related mouse phenotypes are cellular and endocrine/exocrine gland.

UniProtKB/Swiss-Prot:69 Fanconi anemia complementation group B: A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair. Some severe FANCB cases manifest features of VACTERL syndrome with hydrocephalus.

Related Diseases for Fanconi Anemia, Complementation Group B

About this section

Graphical network of diseases related to Fanconi Anemia, Complementation Group B:



Diseases related to fanconi anemia, complementation group b

Symptoms for Fanconi Anemia, Complementation Group B

About this section


Clinical features from OMIM:

300514

Human phenotypes related to Fanconi Anemia, Complementation Group B:

 63 (show all 11)
id Description HPO Frequency HPO Source Accession
1 renal agenesis63 HP:0000104
2 low-set ears63 HP:0000369
3 growth delay63 HP:0001510
4 anemia63 HP:0001903
5 ventriculomegaly63 HP:0002119
6 tracheoesophageal fistula63 HP:0002575
7 abnormality of chromosome stability63 HP:0003220
8 abnormality of the vertebrae63 HP:0003468
9 absent radius63 HP:0003974
10 obsolete lung segmentation defects63 HP:0006525
11 absent thumb63 HP:0009777

Drugs & Therapeutics for Fanconi Anemia, Complementation Group B

About this section

Drugs for Fanconi Anemia, Complementation Group B (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 12)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
SimeprevirapprovedPhase 296923604-59-566576988
Synonyms:
 
Olysio
2
RibavirinapprovedPhase 298436791-04-537542
Synonyms:
1-.beta.-D-Ribofuranosyl-1,2,4-triazolo-3-carboxamide
1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide
1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide
1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide
1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide
1-beta-D-ribofuranosyl-1-H-1,2,4-triazole-3-carboxamide
36791-04-5
437710-49-1
66510-90-5
AA-504/07617051
AB00430481
AC1L1XXZ
AC1Q1IDC
AC1Q4ZGS
AKOS001715163
BB_NC-0567
BPBio1_001195
BRN 0892462
BSPBio_001085
BSPBio_003352
C-Virin
CHEMBL1643
CID37542
Copegus
Copegus (TN)
Cotronak
D00423
DB00811
DRG-0028
DivK1c_000782
Drug: Ribavirin
EU-0101063
FT-0082885
HMS2090L15
HMS2094O09
HMS502H04
HSDB 6513
ICN-1229
IDI1_000782
KBio1_000782
KBio2_002328
KBio2_004896
KBio2_007464
KBio3_002854
KBioGR_001804
KBioSS_002331
KS-1104
LS-1241
Lopac0_001063
MLS000028486
MLS002222317
MolPort-002-507-104
MolPort-002-885-856
NCGC00090726-01
NCGC00090726-03
NCGC00090726-04
NCGC00090726-05
NCGC00090726-06
NCGC00090726-07
NINDS_000782
NSC 163039
 
NSC163039
Prestwick3_000993
R 9644
R-964
R9644_SIGMA
RBV
RG-964
RIBAV
RTC
RTCA
RTP
Ravanex
Rebetol
Rebetol (TN)
Rebetron
Rebretron
Ribacine
Ribamide
Ribamidil
Ribamidyl
Ribasphere
Ribasphere (TN)
Ribav
Ribavirin
Ribavirin (JAN/USP/INN)
Ribavirin Capsules
Ribavirin Triphosphate
Ribavirin [USAN:INN]
Ribavirin-TP
Ribavirina
Ribavirina [INN-Spanish]
Ribavirine
Ribavirine [INN-French]
Ribavirinum
Ribavirinum [INN-Latin]
Ribovirin
Ro 20-9963/000
Ro-20-9963
S2504_Selleck
SCH 18908
SMP1_000261
SMR000058315
SPECTRUM1503938
SR-01000076112-3
Spectrum3_001876
Spectrum4_001252
Spectrum5_002075
Spectrum_001826
Tribavirin
UNII-49717AWG6K
Varazid
Vilona
Viramid
Viramide
Virazid
Virazide
Virazole
Virazole (Ribavirin) Inhalation Solution
Virazole (TN)
Virazole 5'-triphosphate
ZINC01035331
ribavirin
3
Peginterferon alfa-2aapproved, investigationalPhase 2563198153-51-45360545
Synonyms:
198153-51-4
D02747
Pegasys
 
Pegasys (TN)
Peginterferon alfa-2a
Peginterferon alfa-2a (USAN/INN)
Peginterferon alfa-2a (genetical recombination)
Peginterferon alfa-2a (genetical recombination) (JAN)
4HIV Protease InhibitorsPhase 25319
5AntimetabolitesPhase 211774
6
protease inhibitorsPhase 25320
Synonyms:
 
protease inhibitors
7Antiviral AgentsPhase 29732
8Anti-Infective AgentsPhase 221402
9interferonsPhase 22137
10TalazoparibPhase 226
11Poly(ADP-ribose) Polymerase InhibitorsPhase 2309
12VaccinesPhase 16428

Interventional clinical trials:

idNameStatusNCT IDPhase
1A Study of TMC435 in Combination With Pegylated Interferon Alp\Fa-2a and Ribavirin in Patients Infected With Genotype 1 Hepatitis C Virus Who Never Received TreatmentCompletedNCT00882908Phase 2
2Talazoparib Beyond BRCA (TBB) TrialRecruitingNCT02401347Phase 2
3A Study to Evaluate the Safety, Tolerability and Immunogenicity of Ad26.RSV.FA2 Followed by Ad35.RSV.FA2 in Healthy Adult VolunteersCompletedNCT02561871Phase 1
4A Study to Evaluate the Safety, Tolerability and Immunogenicity of Ad35.RSV.FA2 Regimens Boosted With Ad26.RSV.FA2 in Healthy Adult ParticipantsCompletedNCT02440035Phase 1

Search NIH Clinical Center for Fanconi Anemia, Complementation Group B

Genetic Tests for Fanconi Anemia, Complementation Group B

About this section

Genetic tests related to Fanconi Anemia, Complementation Group B:

id Genetic test Affiliating Genes
1 Fanconi Anemia, Complementation Group B26

Anatomical Context for Fanconi Anemia, Complementation Group B

About this section

MalaCards organs/tissues related to Fanconi Anemia, Complementation Group B:

35
Bone marrow, Bone, Lung

Animal Models for Fanconi Anemia, Complementation Group B or affiliated genes

About this section

MGI Mouse Phenotypes related to Fanconi Anemia, Complementation Group B:

40
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053848.1FANCA, FANCB, FANCC, FANCD2, FANCG, FANCL
2MP:00053798.1FANCA, FANCB, FANCC, FANCD2, FANCG, FANCL
3MP:00053897.3FANCA, FANCB, FANCC, FANCD2, FANCG, FANCL

Publications for Fanconi Anemia, Complementation Group B

About this section

Articles related to Fanconi Anemia, Complementation Group B:

idTitleAuthorsYear
1
X-linked inheritance of Fanconi anemia complementation group B. (15502827)
2004

Variations for Fanconi Anemia, Complementation Group B

About this section

Clinvar genetic disease variations for Fanconi Anemia, Complementation Group B:

5
id Gene Variation Type Significance SNP ID Assembly Location
1FANCBFANCB, 1-BP INS, 1838TinsertionPathogenicChr na, -1: -1
2FANCBFANCB, 3314-BP DELdeletionPathogenicChr na, -1: -1
3FANCBFANCB, 1-BP DEL, 1650TdeletionPathogenicChr na, -1: -1
4FANCBFANCB, 1-BP INS, 811TinsertionPathogenicChr na, -1: -1
5FANCBFANCB, IVS7DS, G-A, +5SNVPathogenicChr na, -1: -1
6FANCBFANCB, LEU717TERSNVPathogenicChr na, -1: -1
7FANCBFANCB, 2-BP DEL, 1857AGdeletionPathogenicChr na, -1: -1

Expression for genes affiliated with Fanconi Anemia, Complementation Group B

About this section
Search GEO for disease gene expression data for Fanconi Anemia, Complementation Group B.

Pathways for genes affiliated with Fanconi Anemia, Complementation Group B

About this section

GO Terms for genes affiliated with Fanconi Anemia, Complementation Group B

About this section

Cellular components related to Fanconi Anemia, Complementation Group B according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1Fanconi anaemia nuclear complexGO:00432407.5FANCA, FANCB, FANCC, FANCE, FANCF, FANCG
2nucleoplasmGO:00056546.4FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF

Biological processes related to Fanconi Anemia, Complementation Group B according to GeneCards Suite gene sharing:

(show all 10)
idNameGO IDScoreTop Affiliating Genes
1regulation of CD40 signaling pathwayGO:200034810.1FANCA, FANCD2
2regulation of sequence-specific DNA binding transcription factor activityGO:00510909.9FANCA, FANCD2
3cellular response to oxidative stressGO:00345999.8FANCC, FANCD2
4regulation of inflammatory responseGO:00507279.5FANCA, FANCD2
5ovarian follicle developmentGO:00015419.4FANCF, FANCG
6regulation of regulatory T cell differentiationGO:00455899.2FANCA, FANCD2
7gamete generationGO:00072769.1FANCD2, FANCL
8cellular response to DNA damage stimulusGO:00069748.2FANCD2, FANCF, FANCG, FANCL
9DNA repairGO:00062818.1FANCA, FANCC, FANCG, FANCL
10interstrand cross-link repairGO:00362976.8FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF

Sources for Fanconi Anemia, Complementation Group B

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet